STERILE PROVOCHOLINE SOLUTION PLUS

Pays: Canada

Langue: anglais

Source: Health Canada

Ingrédients actifs:

METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE

Disponible depuis:

METHAPHARM INC

Code ATC:

V04CX

DCI (Dénomination commune internationale):

OTHER DIAGNOSTIC AGENTS

Dosage:

0.25MG; 0.0625MG; 1MG; 4MG; 16MG; 0.125MG; 0.50MG; 2MG; 8MG

forme pharmaceutique:

SOLUTION

Composition:

METHACHOLINE CHLORIDE 0.25MG; METHACHOLINE CHLORIDE 0.0625MG; METHACHOLINE CHLORIDE 1MG; METHACHOLINE CHLORIDE 4MG; METHACHOLINE CHLORIDE 16MG; METHACHOLINE CHLORIDE 0.125MG; METHACHOLINE CHLORIDE 0.50MG; METHACHOLINE CHLORIDE 2MG; METHACHOLINE CHLORIDE 8MG

Mode d'administration:

INHALATION

Unités en paquet:

100

Type d'ordonnance:

Prescription

Domaine thérapeutique:

OTHER DIAGNOSTIC AGENTS

Descriptif du produit:

Active ingredient group (AIG) number: 0951577001; AHFS:

Statut de autorisation:

CANCELLED PRE MARKET

Date de l'autorisation:

2021-04-19

Résumé des caractéristiques du produit

_Page 1 of 34 _
PRESCRIBING INFORMATION
PR
STERILE PROVOCHOLINE
®
SOLUTION,
PR STERILE PROVOCHOLINE
®
SOLUTION PLUS AND
PR
STERILE PROVOCHOLINE
®
SOLUTION 16
methacholine chloride solution for inhalation
0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8, and 16 mg/mL
PR
PROVOCHOLINE
®
methacholine chloride powder USP
100 mg, 160 mg, 320 mg, 1280 mg and 1600 mg
Cholinergic / Diagnostic Aid (Bronchial Asthma)
Methapharm Inc.
Date of Preparation: 31 May 2001
81 Sinclair Blvd.
Brantford, Ontario
Date of Revision: 29 January 2008
N3S 7X6
Control #119812
_Page 2 of 34 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
....................................................................................................7
DOSAGE AND ADMINISTRATION
................................................................................8
OVERDOSAGE
................................................................................................................23
ACTION AND CLINICAL PHARMACOLOGY
............................................................23
STORAGE AND STABILITY
..........................................................................................24
SPECIAL HANDLING INSTRUCTIONS
.......................................................................24
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................25
PART II: SCIENTIFIC INFORMATION
....................